New SoCal Biotech Launches With $55.3M Backed by Novartis, Sanofi and 5AM Ventures Post author:Sam Post published:January 2, 2018 Post category:BioPharma The round was co-led by 5AM Ventures, Kleiner Perkins, Novartis Venture Fund, and Sanofi Ventures. Source: BioSpace You Might Also Like Mauna Kea Technologies: Cellvizio Now CE Marked For Use During Robotic-Assisted Surgery October 9, 2017 ESSA Pharma Provides Business Update And Announces Financial Results For The First Quarter Ended December 31, 2016 February 12, 2017 PhaseRx Reports First Quarter 2017 Financial Results and Provides Corporate Update May 11, 2017
Mauna Kea Technologies: Cellvizio Now CE Marked For Use During Robotic-Assisted Surgery October 9, 2017
ESSA Pharma Provides Business Update And Announces Financial Results For The First Quarter Ended December 31, 2016 February 12, 2017